NHL

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement

Recruiting
  • Lymphoma
  • +4 more
  • Vysis LSI MYC Break Apart Rearrangement Probe Kit
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
Jan 18, 2023

CLL/SLL, NHL, Mantle Cell Lymphoma Trial in United States (SYNCAR-001, STK-009, Cyclophosphamide)

Recruiting
  • CLL/SLL
  • +6 more
  • Duarte, California
  • +4 more
Jan 12, 2023

NHL, DLBCL - Diffuse Large B Cell Lymphoma Trial in Netherlands (ARI-0001, Axi-cel)

Recruiting
  • NHL
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Amsterdam, Netherlands
  • +6 more
Nov 30, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

NHL, Leukemia Trial in Australia (ETH-155008)

Recruiting
  • NHL
  • Leukemia
  • Adelaide, South Australia, Australia
  • +4 more
Jun 8, 2022

CLL/SLL, NHL Trial in China (BN102)

Not yet recruiting
  • CLL/SLL
  • NHL
  • Guangzhou, China
  • +5 more
May 4, 2022

Blood Based Response Monitoring of B-cell Lymphoma Patients

Active, not recruiting
  • NHL
  • No intervention
  • Alkmaar, Netherlands
  • +59 more
Mar 22, 2022

CLL/SLL, NHL, MCL Trial in United States (HMPL-760)

Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
Feb 24, 2022

NHL Trial in Santa Monica (IGN002)

Withdrawn
  • NHL
  • IGN002
  • Santa Monica, California
    UCLA
Feb 23, 2022

NHL, DLBCL Trial in Belgium, Netherlands (Atezolizumab)

Active, not recruiting
  • NHL
  • DLBCL
  • Antwerpen, Belgium
  • +31 more
Jan 19, 2022

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
Aug 12, 2021

NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

Completed
  • NHL
  • +17 more
  • veltuzumab
  • Savannah, Georgia
  • +4 more
Aug 12, 2021

NHL Trial in ChongQing (anti-CD19 CAR NK)

Not yet recruiting
  • NHL
  • anti-CD19 CAR NK
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Nov 19, 2020

Influence of Corn Farming on the Immune System

Completed
  • NHL
    • Iowa City, Iowa
      University of Iowa
    Sep 8, 2020

    Blood Cancer, Leukemia, GVHD Trial in Stanford (non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin,

    Completed
    • Blood Cancer
    • +7 more
    • non-myeloablative hematopoietic cell transplantation
    • +8 more
    • Stanford, California
      Stanford University School of Medicine
    Nov 17, 2019

    NHL Trial in Peking (Decitabine and R-GDP)

    Unknown status
    • NHL
    • Decitabine and R-GDP
    • Peking, Beijing, China
      Peking university third hospital
    May 14, 2018

    Solid Tumors, Multiple Myeloma, Non-Hodgkins Lymphoma Trial in United States (DCR-MYC)

    Terminated
    • Solid Tumors
    • +5 more
    • Stanford, California
    • +5 more
    Dec 13, 2017

    CML, AML, MDS Trial in Philadelphia (Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells, Observation Arm)

    Completed
    • CML
    • +6 more
    • Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
    • Observation Arm
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 17, 2016

    ALL, ANLL, MDS Trial (Naive T-cell Depleted Stem Cell Transplant, Stem Cell Transplant No Manipulation, Isolex device from

    Terminated
    • ALL
    • +3 more
    • Naive T-cell Depleted Stem Cell Transplant
    • +2 more
    • (no location specified)
    Sep 25, 2013

    Non-Myeloablative Allogeneic Stem Cell Transplantation With

    Completed
    • Acute Myeloid Leukemia
    • +10 more
      • San Francisco, California
        University of California San Francisco
      Nov 7, 2012